Differences in waveforms of cerebral evoked potentials among healthy subjects, schizophrenics, manic-depressives and epileptics by Ikuta, Takumi et al.
INTRODUCTION
Originally, each of cerebral EP (Evoked Potential)
s ; SEP (somatosensory EP), VEP (visual EP) or
AEP (auditory EP), was recorded by repeatedly ad-
ministering identical sensory stimuli to the subject,
and averaging the responses to the stimuli to de-
lineate the waveforms of the individual (averaged)
EP. However, the inter-individual diversity in the
waveform of the individual EP was very large, and it
was therefore difficult to assume the general wave-
form of a human EP.
However, it was confirmed in 1980 that the g-m
(group mean) SEP of 200 healthy subjects of both
sexes converged to a given waveform different,
beyond its 98% confidence belt, from the flat hori-
zontal baseline (1). Then, it was shown in 1982 that
the g-m SEPs of each sex converged to waveforms
that were significantly different (MANOVA (multi-
variate analysis of variance)) from each other (2).
Prior to that, in 1974, in a total of 245 subjects, dif-
ferent waveforms of the g-m SEP among healthy
ORIGINAL
Differences in waveforms of cerebral evoked potentials
among healthy subjects, schizophrenics, manic-depres-
sives and epileptics
Takumi Ikuta, Noriko Furuta, Shouichi Kihara, Masao Okura, Isao Nagamine,
Hiroshi Nakayama, Yasuhito Ishimoto, Yasuhiro Kaneda, Masato Tomotake,
Yumiko Izaki, and Xu Ming
Department of Neuropsychiatry, The University of Tokushima School of Medicine, Tokushima, Japan
Abstract : The differences in the waveform of Cerebral EP (Evoked Potential)s ; SEP,
VEP and AEP, among healthy subjects, schizophrenics, manic-depressives and epileptics
were investigated. In 585 subjects of both sexes comprising these diagnostic groups, 6
channels of EPs, each 2 channels for each sensory modality, were recorded simultane-
ously/parallelly from each subject, without assigning a mental task. Then, waveforms of
the g-m (group mean) EPs of each diagnostic group were superimposed for inspection. Peak
latencies and inter-peak amplitudes of individual EPs were statistically tested among
(ANCOVA) and between (Scheffe’s multiple comparison test) these diagnostic groups for
each channel (modality), and for each sex. The waveforms of g-m EPs of each diagnostic
group differed from each other. The differences of latencies and inter-peak amplitudes
among these diagnostic groups attained to the significant level (P0.05), with more sig-
nificant differences between healthy subjects and each of these pathological diagnostic
groups than between each of these pathological diagnostic groups, for each sex. Thus the
differences in the waveform of EPs among these diagnostic groups were confirmed even
taking the effect of medication on EPs into consideration. These results might suggest the
existence of a waveform for individual EPs specific to each of these diagnostic groups,
for each sex. J. Med. Invest. 54 : 303-315, August, 2007
Keywords : waveforms of evoked potentials, healthy subjects, schizophrenics, manic-depressives, epileptics
Received for publication January 15, 2007 ; accepted June 27,
2007.
Address correspondence and reprint requests to Takumi Ikuta
(Professor emeritus in the University of Tokushima. The former
Professor in the Department of Neuropsychiatry, School of Medi-
cine, in the University), Hakozaki, Higashi-ku, Fukuoka 812-0053,
Japan and Fax : +81-92-651-8883.
The Journal of Medical Investigation Vol. 54 2007
303
subjects, schizophrenics, and epileptics had been
reported for each sex without a statistical test (3).
Furthermore, differences of the waveform of g-m
EPs ; g-m SEP, g-m VEP and g-m AEP, and signifi-
cant differences (P0.05) in peak latencies and
inter-peak amplitudes of individual EPs, between
healthy control subjects and each of schizophrenics
(4-6), manic-depressive illness (7-9), and epileptics
(10, 11) were confirmed by ANCOVA (analysis of
covariance) (4-6, 10, 11) and by Mann-Whitney U-
test (7-9), respectively for each channel (modality),
for each sex, in the previous studies from our De-
partment in 1998.
In this study, using EPs data recorded until 1998
in our Department, we intended to confirm the dif-
ferences in the waveform of EPs among healthy sub-
jects, schizophrenics, manic-depressives and epilep-
tics, respectively, for each sex.
SUBJECTS AND METHODS
Subjects
The 585 subjects in this study comprised healthy
subjects, schizophrenics, manic-depressives and epi-
leptics of both sexes, with no sensory disturbances.
They were widely dispersed in age distribution at the
time of EPs recording, within and among these di-
agnostic groups, and for each sex, except for healthy
subjects (Table 1). All of these patients had been
treated as in/out patients in the Department of Neu-
ropsychiatry, School of Medicine, University of
Tokushima, over a period of up to 40.9 y (mean 6.2
SD 7.2 y) until EPs recording, and their diagnoses
were definitely confirmed retrospectively according
to the course of their illness. These patients met the
diagnostic categories F20.0-20.6 of schizophrenia,
F30.1-30.2, 31.0-31.7, 32.0-32.3 and 33.0-33.4 of af-
fective disorder, and G40.0 and 40.3 of epilepsy in
ICD-10 (12). Schizophrenics had been treated with
neuroleptics ; mainly phenothiazines and butyro-
phenones, manic-depressives with anti-manics, anti-
depressants and mood stabilizers ; lithium carbon-
ate (Li), carbamazepine (CBZ), tri- and tetra-cyclics
and sulpiride, and epileptics with anti-epileptics ;
sodium valproate (VPA), CBZ, diphenylhydantoin
(PHT) and phenobarbital (PB). EPs were recorded
from these patients while they were on concomi-
tant medication, but EPs in 21 (11 males and 10 fe-
males) patients were recorded prior to medication
at their initial visit to the Department, and those in
2 male patients and 1 female patient were recorded
after an accidental unmedicated period of more than
2 weeks. The healthy subjects of both sexes were
unpaid volunteers (young medical doctors in the
Department) and paid volunteers (students in the
University) with normal EEG. In all of these sub-
jects, EPs were recorded with informed consent.
Methods of EPs recording
During the EPs recording, the subjects were re-
clining in a chair, with eyes closed, in a dark shielded
room, air conditioned at 24-25. The subjects
were not assigned any mental task, but were only
instructed to relax.
EPs were evoked by, 1) electric shock stimula-
tion of square wave current with 0.5 ms pulse du-
ration, at the voltage of twitching threshold of the
thumb (mean 88SD 11V), delivered from a con-
stant voltage source, percutaneously to the median
nerve at the right wrist (electronic stimulator SEN-
3201 with isolator SS -102J. Nihon Kohden. The
same hereinafter if not specified), for SEP : 2) flash
stimulation of 0.6 J intensity, from a sound-shielded
xenon tube (Retinograph MSP-2R), delivered 30 cm
in front of the closed eyes, for VEP : and 3) binau-
ral click stimulation of 110 dB (acoustic stimulator
SSS-3100) through a pair of speakers (SH10, 8Ω.
Fostex), 80 cm distant from the ears, for AEP.
During recording, each subject was repeatedly
Table 1. Numbers and age(y) distribution of 585 subjects at the time of EPs recordings for healthy subjects (HEL), schizophren-
ics (SCH), manic-depressives (MDI) and epileptics (EPI), and for males (M), females (F) and both sexes (M+F)
HEL SCH MDI EPI
Number (M+F) 200 181 40 164
M F M F M F M F
Number 100 100 100 81 20 20 99 65
Mean(y) 25.4 21.6 33.6 37.1 40.5 46.6 35.9 36.0
SD(y) 3.1 2.6 10.4 13.7 13.8 16.5 13.1 15.0
Range(y) 20-34 19-36 17-75 15-67 20-69 20-79 9-78 12-77
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stimulated by a single 1) electric shock, 2) flash and
3) click in cyclical order. A shock was followed 1 s
later by a flash, the flash was then followed 2 s later
by a click, and then the click was followed 2 s later
by the next electric shock, so that the ISI (inter-
stimulus interval) between the stimuli of the same
sensory modality was always 5 s. Consequently, SEP,
VEP and AEP were recorded simultaneously/par-
allelly from each individual subject in about 8 min
20 s (13).
Recording electrodes were placed on the sub-
ject’s scalp on their left hemisphere, according to
the 10-20 international electrode system (14). SEP
was derived from the derivation (C3’-F 3’) and (C
3’-A1). F3’ is 5 cm anterior and C3’ is 2 cm poste-
rior to the midcoronal line, on the parasagittal line
6.5 cm left of the vertex (1). VEP and AEP were
derived from each 2 derivations (O1-A1), (O1-Cz)
and (Cz-A1), (Cz-T5) (15, 16). Recording electrode
resistances were kept around 5 kΩ.
EEGs containing EPs were derived from the 6
derivations into each corresponding (1st to 6th)
channel of an EEG amplifier (3 sets of AB-622M),
with band pass filter settings of 0.1-100Hz, time con-
stant 0.1 s and a gain of 20,000. These amplified
EEGs were recorded into the corresponding chan-
nel of magnetic tape using a data recorder (XR-50L,
TEAC), together with each of the trigger pulses for
SEP, VEP and AEP into each of another channel.
Reproducing the magnetic tape, the 6 channels of
EPs of 1024 ms of analysis time were triggered by
each corresponding trigger pulse, and averaged 100
times, by the 6 channels of EP recording equipment
(3 sets of ATAC-210) at 1024 Hz sampling rate, by
visually monitoring and manually avoiding the con-
tamination of noise. Thus, 6 channels of individual
(averaged) EPs ; Ch(channel)1SEP(C3’-F3’), Ch
2VEP(O1-A1), Ch3AEP(Cz-A1), Ch4SEP(C3’-A
1), Ch5VEP(O1-Cz) and Ch6AEP(Cz-T5) were
recorded simultaneously/parallelly from each of
the subjects.
These EPs data were recorded as a waveform plot-
ted by a X-Y plotter, and as a time series of 1024 digi-
tal data recorded into an 8-inch floppy disk using a
universal computer (U-1100, PANAFACOM), and
subjected to further data analysis.
Methods of data processing
To avoid the interference of sex factor (2, 17-20),
EPs data were analysed separately for each sex.
The axis of each individual EPs waveform was
adjusted by the method of least squares, to elimi-
nate the tendency to be biassed by the conditions
in the recording system.
Inter-individually averaging the individual (aver-
aged) EPs on 1024 data points, the waveforms of the
g-m (group mean) EPs (21) ; g-m SEP, g-m VEP and
g-m AEP were delineated respectively for each chan-
nel (modality), for each diagnostic group ; healthy
subjects (HEL), schizophrenics (SCH), manic-
depressives (MDI) and epileptics (EPI), respectively,
for each sex. Then the waveforms of g-m EPs of
the 4 diagnostic groups were superimposed on the
same coordinate plane, and compared with each
other for each channel (modality), for each sex.
Superimposing on the CRT display, the peaks in
the g-m EPs in each diagnostic group were identi-
fied referring to those in the schematic average
profile of EPs (22) of healthy subjects in our De-
partment, respectively, for each channel, for each
sex. Similarly, the peaks in each individual EPs were
identified by referring to those in the schematic av-
erage profile of EPs of the corresponding diagnos-
tic group, respectively, for each channel, for each
sex. Next, the differences of peak latencies and inter-
peak amplitudes between the main peaks of opposite
polarity were tested among the 4 diagnostic groups
by ANCOVA after eliminating the effect of age, re-
spectively, for each channel, for each sex. Further-
more, the differences between peak latencies and
inter-peak amplitudes were tested by Scheffe’s mul-
tiple comparison test between each 2 (a pair) of
these among the 4 diagnostic groups, for 6 pairs ;
HEL : SCH, HEL : MDI, HEL : EPI, SCH : MDI,
SCH : EPI and MDI : EPI, respectively for each chan-
nel, for each sex.
RESULTS
Large diversity in the waveform of individual EPs
The diversity in the waveform of individual (av-
eraged) EPs was very large among the subjects.
Therefore, it was difficult to assume the general
waveform of human EPs, even those of healthy
adults of very close age distribution ; males mean
25.4SD 3.1 y, females 21.62.6 y, and even with
EP of identical sensory modality ; SEP (Fig 1).
Differences in the waveform of the group mean EPs
among the 4 diagnostic groups
In the waveform of the g-m (group mean) EPs,
each of 8 positive (P1-8) and negative (N1-8) peaks
were identified with 1024 ms latency, which was in
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agreement with the previous studies in our De-
partment (4-11, 17-20). The g-m EPs ; g-m SEP, g-
m VEP and g-m AEP, superimposed on the same
coordinate plane, had different waveforms among
the 4 diagnostic groups ; healthy subjects, schizo-
phrenics, manic-depressives and epileptics for each
channel (sensory modality), for each sex (Fig. 2, 3).
The waveforms of g-m SEP were complicated,
consisting of 2 main positive peaks P3 and P6 with
preceeding and intervening negative peaks N1 and
N3. The average latencies of SEP peaks in Ch4SEP
(C3’-A1) of healthy males were N1 ; mean 19.9SD
1.8 ms, P3 ; 45.24.0 ms, N3 ; 69.59.1 ms and P6 ;
270.520.4 ms.
The waveforms of g-m VEP were rather simple,
consisting of the main positive peak, which tended
to split into P4, 5 and 6, with preceding and follow-
ing negative peaks N3 and N7. The average laten-
cies of the VEP peaks in both Ch2VEP(O1-A1) and
Ch5VEP(O1-Cz) of healthy subjects of both sexes
showed the following rangs N2 ; 37.2-44.7 ms, P3 ;
48.6-53.1 ms, N3 ; 68.5-73.1 ms, P4 ; 96.8-106.8 ms,
N4 ; 111.8-126.2 ms, P5 ; 135.0-155.2 ms and N7 ;
340.3-351.5 ms.
The waveforms of g-m AEP were the most simple,
consisting of the main positive peak P5, with pre-
ceding and following negative peaks N4, N5 and N7.
The average latencies of AEP peaks in both Ch3AEP
(Cz-A1) and Ch6AEP(Cz-T5) of healthy subjects
of both sexes showed the following rangs P3 ; 55.8-
57.1 ms, N4 ; 103.3-110.0 ms, P5 ; 161.4-179.5 ms,
N5 ; 271.5-275.5 ms, P7 ; 425.4-451.8 ms and N7 ;
465.0-489.3 ms.
Differences in peak latencies in EPs among the 4
diagnostic groups
The differences in the 16 peak latencies in EPs
waveforms when tested by ANCOVA after eliminat-
ing the effect of age among the 4 diagnostic groups,
for each channel (modality), for each sex attained to
the significant level (P0.05). The differences were
more significant for N2 and P3 in SEP, P3, N3 and
P5 in VEP, and P3, N4 and P5 in AEP. The numbers
and ratios of the peak latencies with significant dif-
ferences were lower among males 31%(32/96) than
among females 47%(45/96) (Table 2).
The differences in the 16 pairs of peak latencies in
EPs waveforms between any 2 (a pair) among the 4
diagnostic groups, 6 pairs, when tested by Scheffe’s
multiple comparison test, for each channel (modal-
ity), for each sex attained to the significant level
(P0.05). The numbers and ratios of pairs with sig-
nificant differences were higher between healthy sub-
jects and each of these pathological diagnostic groups
(males : 13%(38/288), females : 19%(56/288)), than
between each of these pathological diagnostic groups
(males : 4.5%(13/288), females : 7.3%(21/288)), and
finally lower between males 8.9%(51/576) than be-
tween females 13%(77/576) (Table 3).
Differences in inter-peak amplitudes in EPs among
the 4 diagnostic groups
Differences of 7 inter-peak amplitudes, including
main peaks of EPs waveforms tested by ANCOVA
after eliminating the effect of age among the 4 diag-
nostic groups, for each channel (modality), for each
sex attained to the significant level (P0.05). The
numbers and ratios of the inter-peak amplitudes with
significant differences were higher among males 76%
(32/42) than among females 64%(27/42) (Table 4).
The differences in 20 inter-peak amplitudes, in-
cluding the main peaks, between any 2 (a pair)
among the 4 diagnostic groups, 6 pairs, when tested
by Scheffe’s multiple comparison test, for each chan-
nel (modality), for each sex attained to the signifi-
cant level (P0.05). The numbers and ratios of the
pairs with significant differences were higher be-
tween healthy subjects and each of the pathological
diagnostic groups (males : 16%(57/360), females :
30% (108/360)) than between each of the patho-
logical diagnostic groups (males : 10%(36/360), fe-
males : 6.7%(24/360)), and lower between males
13%(93/720) than between females 18%(132/720)
(Table 5).
Fig. 1 Large diversity in the waveforms among 200 individual
SEPs of healthy adults of both sexes, with close age distribution.
Waveforms of 200 individual (averaged) SEPs of 100 each males
(mean 25.4SD 3.1 y, black lines) and females (21.62.6 y,
red lines), superimposed on the same coordinate plane at regu-
lar time intervals, up to 500 msec in latency. Scales of amplitude
are comparative, 2570 corresponds to 10μV.
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Fig. 2 Different waveforms of group mean EPs among healthy subjects, schizophrenics, manic-depressives and epileptics for each
channel (modality), for males
Waveforms of group mean EPs ; of healthy subjects (HEL, black line), schizophrenics (SCH, red line), manic-depressives (MDI,
green line) and of epileptics (EPI, blue line), superimposed on the same coordinate plane at logarithmic time intervals up to 1024 ms
in latency, for each Ch (modality) in males. Ch represents channel. Scales of amplitude are comparative, 2570 corresponds to 10μV.
Left panels are Ch1SEP (C3’-F3’), Ch2VEP (O1-A1) and Ch3AEP (Cz-A1), and right panels are Ch4SEP (C3’-A1), Ch5VEP
(O1-Cz) and Ch6AEP (Cz-T5) from top to bottom. Upward deflections are positive, and downward ones are negative peaks,
suffixed by the arabic ordinal numeral of the same color as the peak, indicating N4, P5, etc.
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Fig. 3 Different waveforms of group mean EPs among healthy subjects, schizophrenics, manic-depressives and epileptics for each
channel (modality), for females
Waveforms of group mean EPs ; of healthy subjects (HEL, black line), schizophrenics (SCH, red line), manic-depressives (MDI,
green line) and of epileptics (EPI, blue line), superimposed on the same coordinate plane at logarithmic time intervals up to 1024 ms
in latency, for each Ch (modality) in females. Ch represents channel. Scales of amplitude are comparative, 2570 corresponds to 10
μV. Left panels are Ch1SEP (C3’-F3’), Ch2VEP (O1-A1) and Ch3AEP (Cz-A1), and right panels are Ch4SEP (C3’-A1), Ch5
VEP (O1-Cz) and Ch6AEP (Cz-T5) from top to bottom. Upward deflections are positive, and downward ones are negative peaks,
suffixed by the arabic ordinal numeral of the same color as the peak, indicating N4, P5, etc.
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Table 2. Differences in 16 peak latencies in EPs waveforms tested by ANCOVA after eliminating the effect of age, among the 4 di-
agnostic groups ; healthy subjects (HEL), schizophrenics (SCH), manic-depressives (MDI) and epileptics (EPI) for each channel
(modality), for each sex.
Males P1 N1 P2 N2 P3 N3 P4 N4 P5 N5 P6 N6 P7 N7 P8 N8 No.(Ratio) No.(Ratio)
Ch1SEP(C3’F3’) ** ns ns * ** ns ns ns ns ns ns ns ns ns ns ns 3/16(19%)
9/32(28%)
Ch4SEP(C3’A1) ns ns * ns ns ns ns ** ns ns ** ns * ** ns ** 6/16(38%)
Ch2VEP(01A1) ns ns ** ns ** ** ** ** ** ** ns ns ns ** ** ** 10/16(63%)
13/32(41%)
Ch5VEP(O1Cz) ns ns ns ns ** * ns ns * ns ns ns ns ns ns ns 3/16(19%)
Ch3AEP(CzA1) ns ns ** ns ** ns ns ns ns ns * ns ns ns * * 5/16(31%)
10/32(31%)
Ch6AEP(CzT5) ** ** ns ns ** ns ns * ns ns ns ns ns ns ns * 5/16(31%)
Sum 2 1 3 1 5 2 1 3 2 1 2 0 1 2 2 4 32/96(31%)
Females P1 N1 P2 N2 P3 N3 P4 N4 P5 N5 P6 N6 P7 N7 P8 N8 No.(Ratio) No.(Ratio)
Ch1SEP(C3’F3’) * ** ns ** ** ** ns ns ns ns ns ns ** * ns ns 7/16(44%)
11/32(34%)
Ch4SEP(C3’A1) ns ns ns ** ** ns ns ns ns ** * ns ns ns ns ns 4/16(25%)
Ch2VEP(01A1) ns ** ns ** ** ** * * ns ns ns ns ns ns ns * 7/16(44%)
17/32(53%)
Ch5VEP(O1Cz) ** ** ns ns ns ns ns ns * ** ** ** ** ** ** ** 10/16(63%)
Ch3AEP(CzA1) ns ns ** ns ** ** ** ** ** ns ns ns * ns ns ns 7/16(44%)
17/32(53%)
Ch6AEP(CzT5) ns * ** * ns ns ns ** ** ns ns * ** ** * * 10/16(63%)
Sum 2 4 2 4 4 3 2 3 3 2 2 2 4 3 2 3 45/96(47%)
Numbers and ratios (%) of peak latencies with significant differences (**P0.01, *P0.05, ns=not significant) in each Ch (channel)
among the 4 diagnostic groups, for males (above) and females (below).
Table 3. Differences in 16 pairs of peak latencies in EPs waveforms tested by Scheffe’s multiple comparison test, between any 2
(a pair) among the 4 diagnostic groups ; healthy subjects (HEL), schizophrenics (SCH), manic-depressives (MDI) and epileptics
(EPI) for each channel (modality), for each sex.
Males HEL : SCH HEL : MDI HEL : EPI SCH : MDI SCH : EPI MDI : EPI No.(Ratio) No.(Ratio)
Ch1SEP(C3’F3’) 1/16 1/16 0/16 1/16 0/16 1/16 4/96(4.2%)
15/192(7.8%)
Ch4SEP(C3’A1) 0/16 1/16 5/16 0/16 4/16 1/16 11/96(11%)
Ch2VEP(01A1) 4/16 1/16 4/16 0/16 4/16 0/16 13/96(14%)
20/192(10%)
Ch5VEP(O1Cz) 1/16 2/16 4/16 0/16 0/16 0/16 7/96(7.3%)
Ch3AEP(CzA1) 4/16 0/16 2/16 0/16 0/16 0/16 6/96(6.3%)
16/192(8.3%)
Ch6AEP(CzT5) 2/16 4/16 2/16 1/16 0/16 1/16 10/96(10%)
12/96 9/96 17/96 2/96 8/96 3/96
Sum 38/288(13%) 13/288(4.5%) 51/576(8.9%)
Females HEL : SCH HEL : MDI HEL : EPI SCH : MDI SCH : EPI MDI : EPI No.(Ratio) No.(Ratio)
Ch1SEP(C3’F3’) 3/16 3/16 5/16 1/16 2/16 1/16 15/96(16%)
26/192(14%)
Ch4SEP(C3’A1) 4/16 3/16 4/16 0/16 0/16 0/16 11/96(11%)
Ch2VEP(01A1) 0/16 2/16 3/16 0/16 2/16 0/16 7/96(7.3%)
29/192(15%)
Ch5VEP(O1Cz) 10/16 1/16 4/16 2/16 3/16 2/16 22/96(23%)
Ch3AEP(CzA1) 5/16 4/16 1/16 1/16 3/16 2/16 16/96(17%)
22/192(11%)
Ch6AEP(CzT5) 2/16 0/16 2/16 0/16 2/16 0/16 6/96(6.3%)
24/96 13/96 19/96 4/96 12/96 5/96
Sum 56/288(19%) 21/288(7.3%) 77/576(13%)
Numbers and ratios (%) of each pair of peak latencies with significant differences (P0.05), between each pair among the 4 diagnos-
tic groups, respectively for each Ch (channel), for males (above) and females (below).
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Table 5. Differences in 20 pairs of inter -peak amplitudes in EPs waveforms tested by Scheffe’s multiple comparison test, between
any 2 (a pair) among the 4 diagnostic groups ; healthy subjects (HEL), schizophrenics (SCH), manic-depressives (MDI) and epilep-
tics (EPI) for each channel (modality), for each sex.
Males HEL : SCH HEL : MDI HEL : EPI SCH : MDI SCH : EPI MDI : EPI No.(Ratio) No.(Ratio)
Ch1SEP(C3’F3’) 5/20 2/20 3/20 2/20 6/20 2/20 20/120(17%)
49/240(20%)
Ch4SEP(C3’A1) 8/20 4/20 4/20 0/20 9/20 4/20 29/120(24%)
Ch2VEP(01A1) 0/20 1/20 6/20 0/20 5/20 1/20 13/120(11%)
24/240(10%)
Ch5VEP(O1Cz) 5/20 1/20 3/20 0/20 1/20 1/20 11/120(9.2%)
Ch3AEP(CzA1) 4/20 3/20 4/20 1/20 2/20 2/20 16/120(13%)
20/240(8.3%)
Ch6AEP(CzT5) 2/20 1/20 1/20 0/20 0/20 0/20 4/120(3.3%)
24/120 12/120 21/120 3/120 23/120 10/120
57/360(16%) 36/360(10%) 93/720(13%)
Females HEL : SCH HEL : MDI HEL : EPI SCH : MDI SCH : EPI MDI : EPI No.(Ratio) No.(Ratio)
Ch1SEP(C3’F3’) 6/20 6/20 4/20 1/20 2/20 1/20 20/120(17%)
52/240(22%)
Ch4SEP(C3’A1) 10/20 9/20 2/20 1/20 2/20 8/20 32/120(27%)
Ch2VEP(01A1) 2/20 3/20 4/20 2/20 1/20 2/20 14/120(12%)
30/240(13%)
Ch5VEP(O1Cz) 8/20 5/20 1/20 0/20 1/20 1/20 16/120(13%)
Ch3AEP(CzA1) 11/20 4/20 7/20 0/20 1/20 0/20 23/120(19%)
50/240(21%)
Ch6AEP(CzT5) 8/20 7/20 11/20 0/20 1/20 0/20 27/120(23%)
45/120 34/120 29/120 4/120 8/120 12/120
108/360(30%) 24/360(6.7%) 132/720(18%)
Numbers and ratios (%) of each pair of inter -peak amplitudes with significant differences (P0.05), between each pair among the 4
diagnostic groups for each Ch (channel), for males (above) and females (below).
Table 4. Differences in 7 main inter -peak amplitudes in EPs waveforms tested by ANCOVA after eliminating the effect of age,
among the 4 diagnostic groups ; healthy subjects (HEL), schizophrenics (SCH), manic-depressives (MDI) and epileptics (EPI) for
each channel (modality), for each sex.
Males N1P3 P2N2 N2P3 P3N3 N3P6 P3N7 P6N6 No.(Ratio) No.(Ratio)
Ch1SEP(C3’F3’) ** ** ** ** ns ** ** 6/7(86%)
13/14(93%)
Ch4SEP(C3’A1) ** ** ** ** ** ** * 7/7(100%)
N2P3 P3N3 N3P4 N3P5 P5N7 N3P6 P6N6
Ch2VEP(01A1) ** ** ** ** * ** ns 6/7(86%)
10/14(71%)
Ch5VEP(O1Cz) ns ** ** ** * ns ns 4/7(57%)
N1P5 N2P3 N2P5 N3P4 P5N5 N4P5 P5N7
Ch3AEP(CzA1) * ** ** ns ns * * 5/7(71%)
9/14(64%)
Ch6AEP(CzT5) * * ** ns ns * ns 4/7(57%)
Sum 32/42(76%)
Females N1P3 P2N2 N2P3 P3N3 N3P6 P3N7 P6N6 No.(Ratio) No.(Ratio)
Ch1SEP(C3’F3’) * ** ns ns ** ns ns 3/7(43%)
10/14(71%)
Ch4SEP(C3’A1) ** ** ** ** ** ** ** 7/7(100%)
N2P3 P3N3 N3P4 N3P5 P5N7 N3P6 P6N6
Ch2VEP(01A1) ns ns ns ** ** * ns 3/7(43%)
4/14(29%)
Ch5VEP(O1Cz) ** ns ns ns ns ns ns 1/7(14%)
N1P5 N2P3 N2P5 N3P4 P5N5 N4P5 P5N7
Ch3AEP(CzA1) * ** ** ns * ** * 6/7(88%)
13/14(93%)
Ch6AEP(CzT5) ** ** ** ** ** ** ** 7/7(100%)
Sum 27/42(64%)
Numbers and ratios (%) of inter -peak amplitudes with significant differences (**P0.01, *P0.05, ns=not significant) in each Ch
(channel) among the 4 diagnostic groups, for males (above) and females (below).
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DISCUSSION
In order to confirm the differences of waveforms of
EPs among healthy subjects, schizophrenics, manic-
depressives and epileptics, a large number of 3510
(585 subjects6 channels) EPs data from individu-
als with definite clinical diagnoses were collected for
this study. The EPs were recorded simultaneously/
parallelly with SEP, VEP and AEP from each sub-
ject, repeatedly stimulating with a shock, flash and
click in cyclical order. A shock was followed 1 s later
by a flash, the flash was then followed 2 s later by
a click, and then the click was followed 2 s later by
the next electric shock, so that the ISI (inter-stimulus
interval) for the stimuli of identical modality was
always 5 s, and each 2 channels of SEP, VEP and
AEP was recorded separately, in about 8 min 20 s
(13). Longer ISI results in a reduced rate of habitu-
ation (23). The cross-modality depression of the am-
plitude of EP (15%) when stimuli of different modal-
ity are repeated alternatively is smaller than identi-
cal modality depression (28% on average) when iden-
tical stimuli are repeated, with ISI of 2.5 s (24). Thus,
the simultaneously/parallelly recorded EPs from
each subject under his identical physical and men-
tal condition, used in this study, enabled compre-
hensive data processing for all of SEP, VEP and AEP
(13). This method differs from the multimodality
evoked potentials reported by Greenberg (25), in
which SEP, VEP and AEP were each recorded in
different time sessions.
Regarding the peak latencies, the SEP peaks of
healthy males in this study, N1, P3 and N3, corre-
spond respectively to those of Lüders(26), N1 ; mean
17.6standard error 0.23 ms, P2 ; 42.00.35 ms, and
probably to N3 ; 53.50.85 ms recorded from Japa-
nese healthy male adults aged 19-29 y, as inferred
from the similar derivation to that in this study ; 2 cm
posterior to the midcoronal line on the parasagittal
line 7 cm from the vertex, contralateral to the me-
dian nerve stimulated. VEP peaks of healthy sub-
jects of both sexes in this study, N2, P3, N3, P4, N4,
P5 and N7, correspond respectively to those of Ci-
gánek (27), peak I ; negative, mean 39.12SD 4.18
ms, II ; positive, 53.404.42 ms, III ; negative, 73.33
6.36 ms, IV ; positive, 94.197.13 ms, V ; negative,
114.007.41 ms, VI ; positive, 134.69.92 ms and to
VII ; negative, around 300 ms in the figure, by flash-
VEP, recorded from Oz-Pz, with the subjects not
specified sex and age. AEP peaks of healthy sub-
jects of both sexes in this study, P3, N4, P5, N5 and
P7, nearly correspond respectively to those of Pic-
ton and Hillyard (28), P1 ; mean 50SD 4 ms, N1 ;
837 ms, P2 ; 16117 ms, N2 ; 29047 ms and P3 ;
45026 ms, recorded between the vertex and mas-
toid electrodes by clicks with students of unspeci-
fied sex. Thus, the reliability and usefulness of the
method, simultaneous/parallel EPs recording, ap-
plied in this study was verified by getting EPs peaks
corresponding to those of previous reports by other
researchers.
To make the differences in the waveform of EPs
as conspicuous as possible among the 4 diagnostic
groups, non-pathological factors affecting EPs were
reduced or removed as much as possible through-
out the recording and processing of EPs data. EPs
were recorded without assigning any mental task
to the subjects. Flash stimulation to closed eyes
eliminated the need for subjects of making an effort
to gaze at pattern reversal stimulation. The interfer-
ence of sex factors (2, 17-20), in which different
waveforms of g-m EPs with larger amplitudes and a
tendency for shorter latencies are seen in females
than in males, was avoided by processing all EPs
data separately for each sex.
Dysfunctions (disorganization) of hyper-activated
dominant hemisphere were reported in neuropsy-
chological investigations, including EEG, in schizo-
phrenics. Also, schizophrenic and paranoid symp-
tomatology is related to dominant temporal limbic
dysfunction in epilepsy, whereas manic-depressive
syndromes reflect non-dominant limbic dysfunction
(29, 30). Regarding the waveform stability of EPs,
lower stability than in normal subjects, and lower
stability in the left than in the right hemisphere in
both schizophrenia and psychotic depression, indi-
cate dysfunctions of the left hemisphere (31). Also,
a significant positive correlation between the sever-
ity of positive thought disorder and left regional cere-
bral blood flow measured by PET (32), and local-
ized reduction in the volume of gray matter of the
posterior superior temporal lobe related to the de-
gree of the total thought disorder score were ob-
served by MRI in the left temporal lobe in schizo-
phrenics (33). Because more than 85% of our sub-
jects were right-handed (34), all EPs used in this
study were recorded from the left hemispheres of the
subject. SEP was derived from the derivation (C3’-
F3’) and (C3’-A1), modifying those of Shagass and
Schwartz (35). VEP was derived from (O1-A1) and
(O1-Cz), and AEP from (Cz-A1) and (Cz-T5). Each
2 derivations for VEP and AEP were selected ac-
cording to the ratio of “deviation” between VEP and
AEP, so as to record each of them as selectively as
The Journal of Medical Investigation Vol. 54 August 2007 311
possible, including their long latency components of
up to 1000 ms latency. The “deviation” is the value
of the area encircled by the waveform and baseline
(15, 16), after adjusting the axis of the EPs waveform
against baseline so that the value is minimum (36).
Finally, these derivations confirmed that stimulus
intensities of 0.6 J for flash-VEP and 110 dB for click-
AEP were optimal (37).
Long latency SEP components, more than 20 ms
latency, are generated in the somatosensory cortex
(38). Early flash VEP components arise in the pri-
mary visual cortex, while the later flash components,
including P2 (120 ms), are generated in the secon-
dary visual cortex or visual association areas (39).
Middle latency components of AEP up to 50 ms in
latency originate from the mid-brain and primary
cortical projection area, and later components, 50-
600 ms in latency, originate from secondary, 3rd and
4th cortical projection areas (40). Early EP compo-
nents, up to 100 ms in latency, are thought to be
concerned with transmission of information, and
later components are thought to reflect information-
processing and to be related to attentive activity (41),
and possibly to psychiatric events. Furthermore, a
positive peak with about 800 ms latency was reported
in deep sleep (42). Therefore, in this study, EPs
including later components with up to 1024 ms la-
tency were recorded and subjected to data analysis.
Although the differences of latencies and ampli-
tudes of the components of EPs between psychot-
ics and healthy subjects had been reported to vary
for each sensory modality and for different research-
ers, and even between subgroups within each major
diagnostic group. In general, the latencies of the
long latency components, more than 80 ms latency,
tend to increase and their amplitudes to decrease
in psychotics, and there is higher waveform vari-
ability in the later components in psychotics than
in healthy subjects (21, 43). Prolonged latencies of
EPs were also reported in epileptics (44).
Furthermore, in this study, differences in the wave-
form of EPs among healthy subjects, schizophrenics,
manic-depressives and epileptics were confirmed
by the results that 1) The different waveforms of g-m
EPs among the 4 diagnostic groups for each chan-
nel (modality), for each sex, by inspection. 2) The
differences in latencies and inter-peak amplitudes
among the 4 diagnostic groups attained to the sig-
nificant level by ANCOVA after eliminating effect of
age for each channel (modality), for each sex. 3) The
numbers and ratio of pairs of latencies and inter-
peak amplitudes with significant differences by
Scheffe’s multiple comparison test, which were
higher between healthy subjects and each of these
pathological diagnostic groups than between the
pathological diagnostic groups, for each sex.
Almost all patients in this study were on medica-
tion. Medications alter EPs in various ways. Minor
tranquillizers tend to increase latencies of early com-
ponents and decrease the amplitudes. Psychoexci-
tants such as amphetamine shorten latencies and
increase amplitudes. Antipsychotics tend to increase
latencies and decrease amplitudes of early compo-
nents. Antidepressants tend to decrease latencies
and amplitudes of early components, and increase
latencies of later components (21). Antiepileptics
also tend to increase the latencies of EPs (44).
However, in the previous studies in our Depart-
ment, less significant (P0.05) differences of laten-
cies and inter-peak amplitudes of EPs in schizophren-
ics medicated with neuroleptics, between those tak-
ing more than and less than 600 mg/day of chlor-
promazine equivalent, than between those patients
and healthy subjects were confirmed by ANCOVA
after eliminating the effect of age, for each sex (4-6).
No dose-related effect of neuroleptics on AEP was
found in schizophrenics in a study including un-
medicated patients by Jones and Callaway (45). In
manic-depressives on concomitant medications, no
or less significant differences in latencies and inter-
peak amplitudes in EPs between the patients taking
and not taking each of Li or CBZ, than between each
of these patients and healthy subjects was found by
U-test, for each sex (7-9). Similarly, in epileptics on
concomitant medications, less significant differences
in latencies and inter-peak amplitudes in EPs be-
tween these patients taking and not taking each of
these anti-epileptics ; CBZ, PB, VPA or PHT, than
between each of these patients and healthy subjects
were confirmed by ANCOVA after eliminating the
effect of age, for each sex (10, 11). Furthermore, the
relevant peaks were mostly different between healthy
subjects and these patients and between medicated
and not medicated patients (4-11). These results
were in accord with the results obtained by Scheffe’s
multiple comparison test in this study, in which the
numbers and ratio of pairs of latencies and inter-
peak amplitudes with significant differences were
higher between healthy subjects and these patho-
logical diagnostic groups than between each of these
pathological diagnostic groups, for each sex. There-
fore, the differences in the waveforms of EPs, includ-
ing those of latencies and inter-peak amplitudes,
among these diagnostic groups confirmed in this
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study can not be attributed entirely to the effects of
medication, but must also be attributed to the patho-
logical factor of each diagnostic group.
Differences in the waveforms of EPs among healthy
subjects, schizophrenics, manic-depressives and epi-
leptics were confirmed in this study, without divid-
ing the diagnostic groups into their subtypes or dif-
ferent conditions of the subject groups, such as
manic or depressive. The 3 pathological diagnostic
groups subjected to this study correspond to the pre-
vious rough concept of the 3 circles of major psy-
choses by Jaspers, 1948 (46) ; genuine (idiopathic
(47)) epilepsy, schizophrenia and manic-depressive
illness. This might suggest the existence of a wave-
form for individual EPs specific to each of these ma-
jor diagnostic groups, for each sex. Further it sug-
gests the possibility of making an objective neuropsy-
chiatric diagnosis based on the waveform of EPs.
ACKNOWLEDGEMENTS
The authors wish to thank the members of the
Department of Neuropsychiatry, The University of
Tokushima School of Medicine, until 1998, for their
cooperation for the preparation of this study, and
also for volunteering themselves as control healthy
subjects.
REFERENCE LIST
1. Ikuta T, Furuta N, Kondo K, Ohe S : The wave-
form of the group mean SEP of normal human
subjects. Electroencephalogr Clin Neurophysiol
49 : 250-256, 1980
2. Ikuta T, Furuta N : Sex differences in the hu-
man group mean SEP. Electroencephalogr Clin
Neurophysiol 54 : 449-457, 1982
3. Ikuta T : Somatosensory evoked potentials (SEP)
in normal subjects, schizophrenics and epilep-
tiocs. Fukuoka Acta Med 65 (in Japanese with
English abstract) : 1010-1019, 1974
4. Okura M, Ikuta T, Tada K, Furuta N, Okada
K, Nakayama H, Yamanishi K : Somatosensory
evoked potential (SEP) in schizophrenics.
Shikoku Acta Medica 54 (in Japanese with Eng-
lish abstract) : 152-159, 1998
5. Okura M, Ikuta T, Tada K, Okada K, Furuta
N, Nakayama H, Yamanishi K : Visual evoked
potential (VEP) in schizophrenics. Shikoku Acta
Medica 54 (in Japanese with English ab-
stract) : 144-151, 1998
6. Tada K, Okura M, Ikuta T, Yoshimatsu M, Ito
Y : Auditory evoked potential (AEP) in schizo-
phrenia. Shikoku Acta Medica 54 (in Japanese
with English abstract) : 128-134, 1998
7. Kawabata S, Yoshimatsu M, Okura M, Ikuta T,
Okada K : Manic-depressive illness (MDI) and
somatosensory evoked potential (SEP). Shik-
oku Acta Medica 54 (in Japanese with English
abstract) : 50-62, 1998
8. Yoshimatsu M, Okura M, Kawabata S, Ikuta
T, Okada K : Visual evoked potential (VEP) in
manic depressive illness (MDI). Shikoku Acta
Medica 54 (in Japanese with English abstract) :
75-88, 1998
9. Okada K, Yoshimatsu M, Okura M, Ikuta T,
Kawabata S : Auditory evoked potential (AEP)
in manic-depressive illness (MDI). Shikoku
Acta Medica 54 (in Japanese with English ab-
stract) : 63-74, 1998
10. Koyama K, Nakayama H, Okura M, Ikuta T,
Kawamura I : The differences in VEP (visual
evoked potentials) between epileptics and nor-
mal subjects. Shikoku Acta Medica 54 (in Japa-
nese with English abstract) : 119-127, 1998
11. Nakayama H, Koyama K, Okura M, Ikuta T :
The differences in AEP (auditory evoked po-
tentials) and SEP (somatosensory evoked po-
tentials) between epileptics and normal sub-
jects. Shikoku Acta Medica 54 (in Japanese
with English abstract) : 160-172, 1998
12. World Health Organization : The ICD-10 Clas-
sification of Mental and Behavioral Disorders.
Diagnostic criteria for research. WHO, Geneva,
1992
13. Japanese patent office : Jp patent P3142121-
2000 : Measuring apparatus for electric poten-
tial induced by cerebrum. Inventor, patentee
Ikuta T, Japanese patent gazette 2001.3.7
14. Jasper H : The ten-twenty electrode system of
the international Federation. Electroencepha-
logr Clin Neurophysiol 10 : 371- 375, 1958
15. Enai T, Saito K : The electrode settings based
on the 10-20 electrode system for the selective
recording of the AEP (Auditory Evoked Po-
tential). Shikoku Acta Medica 41 (in Japanese
with English abstract) : 215-227, 1985
16. Saito K, Enai T : The electrode settings based
on the 10-20 electrode system for the selective
recording of the VEP (Visual Evoked Poten-
tial). Shikoku Acta Medica 41 (in Japanese with
English abstract) : 263-277, 1985
The Journal of Medical Investigation Vol. 54 August 2007 313
17. Shagass C, Schwartz M : Somatosensory evoked
responses in psychotic depression. Br J Psy-
chiatry 112 : 779-807, 1966
18. Kagawa K, Nakayama H, Kaneda Y, Ikuta T,
Karisya K : Sex differences in somatosensory
evoked potential (SEP) and EEG of healthy
adults. Shikoku Acta Medica 54 (in Japanese
with English abstract) : 39-49, 1998
19. Kaneda Y, Nakayama H, Kagawa K, Furuta N,
Ikuta T : Sex differences in visual evoked poten-
tial and electroencephalogram of healthy adults.
Tokushima J Exp Med 43 : 143-157, 1996
20. Nakayama H, Kaneda Y, Kagawa K, Nagamine
I, Karisha K, Furuta N, Ikuta T : Sex differ-
ences in auditory evoked potential (AEP) and
EEG of healthy adults. Shikoku Acta Medica
52 (in Japanese with English abstract) : 1-13,
1996
21. Shagass C : Evoked potentials in adult psychia-
try. In : EEG and evoked potentials in psychia-
try and behavioral neurology. Butterworths,
Boston. 1983, pp.169-210
22. Floris V, Morocutti G, Amabile G, Bernardi G,
Rizzo PA : Recovery cycle of visual evoked po-
tentials in normal, schizophrenic and neurotic
patients. In : Kline NS, Laska E, eds. Comput-
ers and Electronic Devices in Psychiatry, Grune
and Stratton, New York, 1968, pp.194-205
23. Tomberg C, Desmedt JE, Ozaki I, Nguyen TH,
Chalklin V : Mapping somatosensory evoked
potentials to finger stimulation at intervals of
450 to 4000 msec and the issue of habituation
when assessing early cognitive components.
Electroencephalogr Clin Neurophysiol 74 : 347-
358, 1989
24. Hay IS, Davis H : Slow cortical evoked poten-
tials : Interactions of auditory, vibro-tactile and
shock stimuli. Audiology 10 : 9-17, 1971
25. Greenberg RP, Mayer DJ, Becker DP, Miller
JD : Evaluation of brain function in severe hu-
man headtrauma with multimodality evoked
potentials. Part 1 : evoked brain-injury poten-
tials, methods and analysis. J Neurosurg 47 :
150-162, 1977
26. Lüders H : The effects of aging on the wave
form of the somatosensory cortical evoked po-
tential. Electroencephalogr Clin Neurophysiol
29 : 450-460, 1970
27. Cigánek L : The EEG response (evoked poten-
tial) to light stimulus in man. Electroencepha-
logr Clin Neurophysiol 13 : 165-172, 1961
28. Picton TW, Hillyard SA : Human auditory evoked
potentials. II : Effects of attention. Electroen-
cepharogr. Clin Neurophysiol 36 : 191-199,
1974
29. Flor-Henry P : Ictal and interictal psychiatric
manifestations in epilepsy : Specific or Non-
specific? A critical review of some of the evi-
dence. Epilepsia 13 : 773-783, 1972
30. Flor-Henry P : Lateralized temporal-limbic dys-
function and psychopathology. Ann NY Acad
Sci 280 : 777-795, 1976
31. Shagass C, Romer RA, Straumanis JJ, Amadeo
M : Evoked potential evidence of lateralized
hemispheric dysfunction in the psychoses. In :
Gruzelier J, Flor-Henry P, eds. Hemispheric
asymmetries of function in psychopathology.
Elsevier, North Holland : 1979, pp.293-316
32. McGuire PK, Quested DJ, Spence SA, Murray
RM, Frith CD, Liddle PF : Pathophysiology of
‘positive’ thought disorder in schizophrenia.
Br J Psychiatry 173 : 231-235, 1998
33. Shenton ME, Kikinis R, Jolesz FA, Pollak SD,
LeMay M, Wible CG, Hokama H, Martin J,
Metcalf D, Coleman M, McCarley W : Abnor-
malities of the left temporal lobe and thought
disorder in schizophrenia. N Engl J Med 327 :
604-612, 1992
34. Edagawa K, Uemura K, Yoshimatu M, Okura
M, Ikuta T : Differences of visual evoked po-
tentials (VEPs) evoked by contralateral or ip-
silateral monocular and binocular flash stim-
uli. Shikoku Acta Medica 53 (in Japanese
with English abstract) : 258-268, 1997
35. Shagass C, Schwartz M : Recovery functions
of somatosensory peripheral nerve and cere-
bral evoked responses in man. Electroencepha-
logr Clin Neurophysiol 17 : 126-135, 1964
36. Furuta N, Enai T, Saito K, Maeda M, Ikuta T :
The procedure to get minimum deviation for
the data processing of evoked potential study.
Tokushima J Exp Med 32 : 31-38, 1985
37. Maeda M, Yano K, Wada K : The optimal stimu-
lus intensities for the selective recording of VEP
and AEP. Shikoku Acta Medica 42 (in
Japanese with English abstract) : 245-269,
1986
38. Allison T, McCarthy G, Wood CC, Williamson
PD, Spencer DD : Human cortical potentials
evoked by stimulation of the median nerve. II.
Cytoarchitectonic areas generating long-latency
activity. J Neurophysiol 62 : 711-722, 1989
39. Wright CE, Drasdo N, Harding GFA : Pathol-
ogy of the optic nerve and visual association ar-
T. Ikuta, et al. EPs waveform differences in neuropsychiatry314
eas. Brain 110 : 107-120, 1987
40. Davis H : Principles of electric response audi-
ometry : Ann Otol Rhinol Laryngol 85 (Suppl
28, No.3, part 3) : 5-96, 1976
41. Straumanis Jr JJ, Shagass C, Roemer RA,
Mendels J, Ramsey A : Cerebral evoked poten-
tial changes produced by treatment with lithium
carbonate. Biol Psychiatry 16 : 113-129, 1981
42. Osterhammel PA, Davis H, Wier CC, Hirsh SK :
Adult auditory evoked vertex potentials in sleep.
Audiology 12 : 116-128, 1973
43. Buchsbaum MS : The middle evoked response
components and schizophrenia. Schizophr Bull
3 : 93-104, 1977
44. Mervaala E, Keränen T, Penttilä M, Partanen
JV, Riekkinen P : Pattern-reversal VEP and cor-
tical SEP latency prolongations in epilepsy. Epi-
lepsia 26 : 441-445, 1985
45. Jones RT, Callaway E : Auditory evoked re-
sponses in schizophreniaA reassessment. Biol
Psychiatry 2 : 291-298, 1970
46. Jaspers K : Die Einteilung der Krankheiten
(Diagnosenschema). In : Allgemeine Psycho-
pathologie. 5 Auflage, Springer, Berlin, 1948,
pp.506-516
47. Penfield W, Jasper H : Etiological classification.
In : Epilepsy and the functional anatomy of the
human brain. Little, Brown & Company, Boston,
1954, pp.13-14
The Journal of Medical Investigation Vol. 54 August 2007 315
